Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

搜集汇总

背景与挑战

背景概述

该数据集源自ALLHAT试验，旨在评估高风险高血压患者中，血管紧张素转换酶抑制剂、钙通道阻滞剂与利尿剂在预防心脏病发作方面的主要结局比较。